Primaquine pharmacokinetics in lactating women and breastfed infant exposures
Primaquine is the only drug providing radical cure of Plasmodium vivax malaria. It is not recommended for breastfeeding women as it causes hemolysis in glucose-6-phosphate dehydrogenase (G6PD) deficient individuals, and breast milk excretion and thus infant exposure are not known.Healthy G6PD normal...
Main Authors: | Gilder, M, Hanpithakphong, W, Hoglund, R, Tarning, J, Win, H, Hilda, N, Chu, C, Bancone, G, Carrara, V, Singhasivanon, P, White, N, Nosten, F, McGready, R |
---|---|
פורמט: | Journal article |
שפה: | English |
יצא לאור: |
Oxford University Press
2018
|
פריטים דומים
-
Population pharmacokinetic modelling of primaquine exposures in lactating women and breastfed infants
מאת: Wattanakul, T, et al.
יצא לאור: (2024) -
Population pharmacokinetic modelling of primaquine exposures in lactating women and breastfed infants
מאת: Thanaporn Wattanakul, et al.
יצא לאור: (2024-05-01) -
Mechanistic modeling of primaquine pharmacokinetics, gametocytocidal activity, and mosquito infectivity
מאת: Chotsiri, P, et al.
יצא לאור: (2022) -
Pharmacokinetic interactions between primaquine and chloroquine.
מאת: Pukrittayakamee, S, et al.
יצא לאור: (2014) -
Antimalarial drugs for treating and preventing malaria in pregnant and lactating women
מאת: Saito, M, et al.
יצא לאור: (2018)